Substance P enhances HIV-1 replication in latently infected human immune cells

Journal of Neuroimmunology

Volumn 121, Issue 1-2, 2001, Pages 67-75

  Li, Yuan ^a   Douglas, Steven D ^a   Song, Li ^a   Sun, Shuang ^a   Ho, Wen Zhe ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

AIDS HIV; Cytokines; Immunomodulators; Neuroimmunology

Indexed keywords

2 [1 IMINO 2 (2 METHOXYPHENYL)ETHYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 ONE; 2 BENZHYDRYL 3 (2 METHOXYBENZYLAMINO) 1 AZABICYCLO[2.2.2]OCTANE; CHLORAMPHENICOL ACETYLTRANSFERASE; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; SUBSTANCE P;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CELL LINE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENT CELL; IMMUNOPATHOGENESIS; LONG TERMINAL REPEAT; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS REPLICATION;

ADULT; ANTINEOPLASTIC AGENTS; CARCINOGENS; CELL LINE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, GAG; HIV INFECTIONS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; MONOCYTES; NEUROIMMUNOMODULATION; RECEPTORS, NEUROKININ-1; RNA, MESSENGER; SUBSTANCE P; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA; VIRUS REPLICATION;

EID: 0035803878     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(01)00439-8     Document Type: Article

References (47)

1. HIV-1 gp120 increases the permeability of rat brain endothelium cultures by a mechanism involving substance P
2. Changed levels of substance P and somatostatin in HIV-positive children
3. Central nervous system-immune system interactions: Psychoneuroendocrinology of stress and its immune consequences
4. Immune system-central nervous system interactions: Effect and immunomodulatory consequences of immune system mediators on the brain
5. Neurogenic amplification of immune complex inflammation
6. Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by superinfection of nonproductively infected cell lines with recombinant luciferase-encoding viruses
7. In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency
8. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
9. + T cells using a combination of cytokines
10. Disturbed immunoregulatory properties of the neuropeptide substance P on lymphocyte proliferation in HIV infection
11. Detection of substance P immunoreactivity in human peripheral leukocytes
12. Elevated substance P levels in HIV-infected men
13. + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
14. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line
15. Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate
16. Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone
17. Human substance P receptor (NK-1): Organization of the gene, chromosome localization, and functional expression of cDNA clones
18. Interaction between the nervous and immune systems
19. Differential expression of neurokinin-1 receptor by human mucosal and peripheral lymphoid cells
20. The macrophage and HIV-1
21. Monokine-mediated increase in human immunodeficiency virus type 1 expression in chronically infected promonocyte-and T-cell-derived lines
22. Substance P modulates human immunodeficiency virus replication in human peripheral blood monocyte-derived macrophages
23. Substance P augments interleukin-10 and tumor necrosis factor-alpha release by human cord blood monocytes and macrophages
24. Human monocytes and macrophages express substance P and neurokinin-1 receptor
25. Substance P C-terminal octapeptide analogues augment tumor necrosis factor-alpha release by human blood monocytes and macrophages
26. Substance P-induced IL-12 production by murine macrophages
27. Human lymphocytes express substance P and its receptor
28. Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes
29. The neuropeptide substance P stimulates production of interleukin 1 in human blood monocytes: Activated cells are preferentially influenced by the neuropeptide
30. Substance P augments tumor necrosis factor release in human monocyte-derived macrophages
31. Pathogenesis of human immunodeficiency virus infection
32. The neuropeptide substance P activates transcription factor NF-kappa B and kappa B-dependent gene expression in human astrocytoma cells
33. Functional analysis of the proximal CCR5 promoter
34. Effect of neuropeptides on production of inflammatory cytokines by human monocytes
35. Characterization of substance P binding to human monocytes/macrophages
36. Substance P activates NF-kappaB independent of elevations in intracellular calcium in murine macrophages and dendritic cells
37. Substance P and immunoregulation
38. Immunomodulation by tachykinin neuropeptides
39. Substance P precursor and kininogen: Their structures, gene organizations, and regulation
40. Stereospecific receptors for substance P on cultured human IM-9 lymphoblasts
41. Substance P
42. The effect of cytokines and pharmacologic agents on chronic HIV infection
43. Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression
44. Substance P (SP) mediates production of stem cell factor and interleukin-1 in bone marrow stroma: Potential autoregulatory role for these cytokines in SP receptor expression and induction
45. Immunopathogenic mechanisms of HIV infection: Cytokine induction of HIV expression
46. Immunopathogenesis of HIV infection
47. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity